Double bond isomer of trans-resveratrol, the more often studied and naturally abundant of the two resveratrol isomers exhibits antioxidant activity in the micromolar range similar to that observed with trans-resveratrol.
Double bond isomer of trans-resveratrol, the more often studied and naturally abundant of the two resveratrol isomers exhibits antioxidant activity in the micromolar range similar to that observed with trans-resveratrol.
A reversible and competitive inhibitor of type IV collagen-specific MMP-2 and MMP-9 with preference towards MMP-2 (IC50 = 4 and 20 µM, respectively).
A reversible and competitive inhibitor of type IV collagen-specific MMP-2 and MMP-9 with preference towards MMP-2 (IC50 = 4 and 20 µM, respectively).
Double bond isomer of trans-resveratrol, the more often studied and naturally abundant of the two resveratrol isomers exhibits antioxidant activity in the micromolar range similar to that observed with trans-resveratrol.
Double bond isomer of trans-resveratrol, the more often studied and naturally abundant of the two resveratrol isomers exhibits antioxidant activity in the micromolar range similar to that observed with trans-resveratrol.
A nonenzyme-dependent degradation product of rapamycin resulting from ester hydration followed by dehydration secreted from cells by P-glycoprotein poorly activates mTOR but, like rapamycin, inhibits the proteasome.
A nonenzyme-dependent degradation product of rapamycin resulting from ester hydration followed by dehydration secreted from cells by P-glycoprotein poorly activates mTOR but, like rapamycin, inhibits the proteasome.
A reversible and competitive inhibitor of type IV collagen-specific MMP-2 and MMP-9 with preference towards MMP-2 (IC50 = 4 and 20 µM, respectively).
A reversible and competitive inhibitor of type IV collagen-specific MMP-2 and MMP-9 with preference towards MMP-2 (IC50 = 4 and 20 µM, respectively).
A platinum-containing compound that acts as an alkylating agent used alone or in combination therapy in the treatment of several types of cancer inhibits the RecA recombinase of M. tuberculosis (IC<sub>50</sub> = 2 µM), blocking protein
A platinum-containing compound that acts as an alkylating agent used alone or in combination therapy in the treatment of several types of cancer inhibits the RecA recombinase of M. tuberculosis (IC<sub>50</sub> = 2 µM), blocking protein
Double bond isomer of trans-resveratrol, the more often studied and naturally abundant of the two resveratrol isomers exhibits antioxidant activity in the micromolar range similar to that observed with trans-resveratrol.
Double bond isomer of trans-resveratrol, the more often studied and naturally abundant of the two resveratrol isomers exhibits antioxidant activity in the micromolar range similar to that observed with trans-resveratrol.
A reversible and competitive inhibitor of type IV collagen-specific MMP-2 and MMP-9 with preference towards MMP-2 (IC50 = 4 and 20 µM, respectively).
A reversible and competitive inhibitor of type IV collagen-specific MMP-2 and MMP-9 with preference towards MMP-2 (IC50 = 4 and 20 µM, respectively).
An unsaturated short chain fatty acid that is secreted by P. aeruginosa and induces a dispersion response in biofilms formed by gram-negative and gram-positive bacteria, as well as by the yeast C.
An unsaturated short chain fatty acid that is secreted by P. aeruginosa and induces a dispersion response in biofilms formed by gram-negative and gram-positive bacteria, as well as by the yeast C.
A potent anti-mitotic drug that is 100-fold more active than resveratrol at inhibiting the growth of human colon cancer Caco-2 cells inhibits tubulin polymerization in a dose-dependent manner (IC<sub>50</sub> = 4 &muM) and enzymes involved in the
A potent anti-mitotic drug that is 100-fold more active than resveratrol at inhibiting the growth of human colon cancer Caco-2 cells inhibits tubulin polymerization in a dose-dependent manner (IC<sub>50</sub> = 4 &muM) and enzymes involved in the